Search

Your search keyword '"Trifirò, Gianluca"' showing total 1,129 results

Search Constraints

Start Over You searched for: Author "Trifirò, Gianluca" Remove constraint Author: "Trifirò, Gianluca"
1,129 results on '"Trifirò, Gianluca"'

Search Results

1. Acute Appendicitis After COVID-19 Vaccines in Italy: A Self-Controlled Case Series Study

2. What is the Safety of COVID-19 Vaccines in Immunocompromised Patients? Results from the European “Covid Vaccine Monitor” Active Surveillance Study

8. Linking the molecular composition with peatbog status

10. Comparing clinical trial population representativeness to real-world users of 17 biologics approved for immune-mediated inflammatory diseases: An external validity analysis of 66,639 biologic users from the Italian VALORE project

11. Communicating for the Safe Use of Medicines: Progress and Directions for the 2020s Promoted by the Special Interest Group of the International Society of Pharmacovigilance

12. Safety of COVID-19 Vaccines Among the Paediatric Population: Analysis of the European Surveillance Systems and Pivotal Clinical Trials

14. Acid sphingomyelinase deficiency (ASMD): addressing knowledge gaps in unmet needs and patient journey in Italy—a Delphi consensus

23. Deprescribing as a strategy for improving safety of medicines in older people: Clinical and regulatory perspective.

24. Artificial intelligence for optimizing benefits and minimizing risks of pharmacological therapies: challenges and opportunities.

25. Clinical impact of medication review and deprescribing in older inpatients: A systematic review and meta‐analysis.

26. Caserta Record Linkage Database

28. Development and Validation of a META-Algorithm to Identify the Indications of Use of Biological Drugs Approved for the Treatment of Immune-Mediated Inflammatory Diseases from Claims Databases: Insights from the VALORE Project

30. Frequency and timing of adverse reactions to COVID-19 vaccines; A multi-country cohort event monitoring study

32. Frequency and timing of adverse reactions to COVID-19 vaccines; A multi-country cohort event monitoring study

33. What is the Safety of COVID-19 Vaccines in Immunocompromised Patients? Results from the European “Covid Vaccine Monitor” Active Surveillance Study

34. Regional administrative data and their role in planning, programming and controlling at regional level

35. Safety Monitoring of COVID-19 Vaccines in Persons with Prior SARS-CoV-2 Infection: A European Multi-Country Study

36. Frequency and timing of adverse reactions to COVID-19 vaccines; A multi-country cohort event monitoring study

37. Frequency and timing of adverse reactions to COVID-19 vaccines; A multi-country cohort event monitoring study

38. Safety of COVID-19 Vaccines among People with History of Allergy: A European Active Surveillance Study.

39. Understanding Clinical Effectiveness and Safety Implications of Botulinum Toxin in Children: A Narrative Review of the Literature.

41. Post-marketing active surveillance of Guillain Barré Syndrome following COVID-19 vaccination in persons aged ≥12 years in Italy: A multi-database self-controlled case series study

50. Postmarketing active surveillance of myocarditis and pericarditis following vaccination with COVID-19 mRNA vaccines in persons aged 12 to 39 years in Italy: A multi-database, self-controlled case series study

Catalog

Books, media, physical & digital resources